Depression and Anxiety

D&A Journal cover

ADAA members receive a complimentary annual online subscription to Depression and Anxiety. With an impact factor of 4.61, this journal ranks 21 out of 135 in psychiatry journals and 9 out of 75 in psychology journals.

Depression and Anxiety, the official journal of the Anxiety and Depression Association of America, is available online only as of January 2013. The journal welcomes original research and synthetic review articles covering neurobiology (genetics and neuroimaging), epidemiology, experimental psychopathology, and treatment (psychotherapeutic and pharmacologic) aspects of mood and anxiety disorders, and related phenomena in humans.

A priority is placed on papers focusing on treatment, as well as those providing cutting-edge reviews of key areas and issues, in order to enhance the clinical evaluation and care of individuals struggling with the effects of these disorders. All submissions are peer-reviewed; there is no handling or publishing fee.

NOTE: You must be a current member to log in. If you have questions about your login, please contact membership [at] adaa [dot] org (ADAA Membership).

Please note: Three open-access journals, the Journal of Depression & Anxiety (OMICS); Anxiety and Depression Research (Herbert Publications); and Annals of Depression and Anxiety (Austin Publishing) are not affiliated with ADAA. These publishers require payment of a handling or submissions fee from authors; find information about these fees on their websites. These publications are not related to Depression and Anxiety, the official ADAA journal.


The following articles from Volume 31 Number 11 (November 2014) have been posted on the journal website:

Commentaries
Psychiatric Genetics and the Future of Personalized Treatment
Jordan W. Smoller, MD, ScD

Biomarker Studies and the Future of Personalized Treatment for Depression
Maria A. Oquendo, MD, Patrick McGrath, MD, Myrna M. Weissman, PhD

Internet Psychotherapy and the Future of Personalized Treatment
Gavin Andrews, AO, MD, FRCPsych, Alishia D. Williams, PhD

Use of Large Data Sets and the Future of Personalized Treatment
Roy H. Perlis, MD, MSc

Review
Toward the Application of Functional Neuroimaging to Individualized Treatment for Anxiety and Depression
Tali M. Ball, MA, Murray B. Stein MD, MPH, Martin P. Paulus, MD


NEWS

Pre-enlistment Mental Disorders and Suicidality Among New U.S. Army Soldiers
The findings of two new reports from the largest-ever study of mental health risk and resilience in Army personnel show that despite higher rates of current mental disorders and suicidality among U.S. Army soldiers than similarly matched civilians, the rates of most pre-enlistment mental disorders among new soldiers are comparable to those of civilians.

Some pre-enlistment mental disorders and an increased presence of one or more additional disorders are more common among new soldiers than civilians, showing that a history of these disorders is associated with increased probability of volunteering for Army service. In addition, the rates of pre-enlistment suicidality reported by new soldiers are comparable to those reported by non-deployed active-duty soldiers throughout their Army careers and to those of matched civilians.

The results suggest the need for two kinds of interventions: early clinical interventions to help new soldiers reduce chronic pre-enlistment mental disorders, and ongoing preventive interventions to reduce post-enlistment suicides.

Lifetime Prevalence of DSM-IV Mental Disorders Among New Soldiers in the U.S. Army: Results From the Army Study to Assess Risk and Resilience in Servicemembers (Army STARRS)

Prevalence and Correlates of Suicidal Behavior Among New Soldiers in the US Army: Results From the Study to Assess Risk and Resilience among Servicemembers (Army STARRS)


The following articles from Volume 31 Number 10 (October 2014) have been posted on the journal website:

Research Articles

Transdiagnostic Dimensions of Anxiety and Depression Moderate Motivation-Related Brain Networks During Goal Maintenance
Jeffrey M. Spielberg, PhD, Gregory A. Miller, PhD, Stacie L. Warren, PhD, Bradley P. Sutton, PhD, Marie Banich, PhD, Wendy Heller, PhD

Anxiety in Major Depression and Cerebrospinal Fluid Free Gamma-Aminobutyric Acid
J. John Mann, MD, Maria A. Oquendo, MD, Kalycia Trishana Watson, MUPP, Maura Boldrini, MD, PhD,  Kevin M. Malone, MD, Steven P. Ellis, PhD, Gregory Sullivan, MD, Thomas B. Cooper, MA, Shan Xie, PhD, Dianne Currier, PhD

Neurocircuitry Underlying Risk and Resilience to Social Anxiety Disorder
Jacqueline A. Clauss, BA, Suzanne N. Avery, BS, Ross M. VanDerKlok, BA, Baxter P. Rogers, PhD, Ronald L. Cowan, MD, PhD, Margaret M. Benningfield, MD, Jennifer Urbano Blackford, PhD

Amygdala Response to Negative Stimuli Predicts PTSD Symptom Onset Following a Terrorist Attack

Katie A. McLaughlin, PhD, Daniel S. Busso, MA, Andrea Duys, BA, Jennifer Greif Green, PhD, Sonia Alves, BA, Marcus Way, BA, Margaret A. Sheridan, PhD